The Scientist

» tsunami and disease/medicine

Most Recent

image: Theranos in Criminal Probe

Theranos in Criminal Probe

By | April 19, 2016

Federal officials are investigating whether the diagnostics company misled investors.

2 Comments

image: Tracking Zika’s Evolution

Tracking Zika’s Evolution

By | April 15, 2016

Federal officials are investigating whether the diagnostics company misled investors.

1 Comment

image: Psychedelic Neuroimaging

Psychedelic Neuroimaging

By | April 13, 2016

Federal officials are investigating whether the diagnostics company misled investors.

0 Comments

image: Cancer Tissue Repository Launched

Cancer Tissue Repository Launched

By | April 11, 2016

Federal officials are investigating whether the diagnostics company misled investors.

0 Comments

image: Zooming In on an Antidepressant Target

Zooming In on an Antidepressant Target

By | April 6, 2016

Federal officials are investigating whether the diagnostics company misled investors.

0 Comments

image: Contributors

Contributors

By | April 1, 2016

Federal officials are investigating whether the diagnostics company misled investors.

0 Comments

image: Pulling It All Together

Pulling It All Together

By | April 1, 2016

Federal officials are investigating whether the diagnostics company misled investors.

0 Comments

image: Shooting for the Moon

Shooting for the Moon

By | April 1, 2016

Federal officials are investigating whether the diagnostics company misled investors.

4 Comments

image: CDC Offers Advice to Limit Opioid Scripts

CDC Offers Advice to Limit Opioid Scripts

By | March 17, 2016

Federal officials are investigating whether the diagnostics company misled investors.

0 Comments

image: Antibiotic Assistants

Antibiotic Assistants

By | March 9, 2016

Federal officials are investigating whether the diagnostics company misled investors.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech